Sagent Pharmaceuticals is recalling 430,744 vials of methylPREDNISolone Sodium Succinate for Injection, USP, in 40 mg, 125 mg, and 1 gram doses. The recall was initiated because testing showed high levels of an impurity, meaning the drug failed to meet quality and degradation specifications. This medication is a generic steroid used to treat various conditions, and the presence of excessive impurities can affect the safety and effectiveness of the treatment. Consumers who have these vials should contact their healthcare provider or pharmacist, as these products were distributed nationwide.
The product contains levels of an impurity or degradation product that exceed safety specifications. Using a medication with higher-than-allowed impurities can lead to unpredictable side effects or reduced effectiveness of the steroid treatment.
Contact your healthcare provider or pharmacist for guidance. Return any unused product to the pharmacy for a refund
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.